Sánchez-Soliño O - Search Results

1

Effects of Levodopa-Carbidopa Intestinal Gel Compared with Optimized Medical Treatment on Nonmotor Symptoms in Advanced Parkinson's Disease: INSIGHTS Study.

Chung SJ, Calopa M, Ceravolo MG, Tambasco N, Antonini A, Chaudhuri KR, Robieson WZ, Sánchez-Soliño O, Zadikoff C, Jin M, Barbato LM. Chung SJ, et al. Among authors: sanchez solino o. Parkinsons Dis. 2022 Nov 4;2022:1216975. doi: 10.1155/2022/1216975. eCollection 2022. Parkinsons Dis. 2022. PMID: 36388237 Free PMC article.

2

Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: long-term results from COSMOS.

Fasano A, García-Ramos R, Gurevich T, Jech R, Bergmann L, Sanchez-Soliño O, Parra JC, Simu M. Fasano A, et al. Among authors: sanchez solino o. J Neurol. 2023 May;270(5):2765-2775. doi: 10.1007/s00415-023-11615-3. Epub 2023 Feb 18. J Neurol. 2023. PMID: 36802031 Free PMC article.

3

Satisfaction with videoconferencing support for levodopa-carbidopa intestinal gel: An observational study.

Gurevich T, Evans A, Hassin-Baer S, Kägi G, Koziorowski D, Roszmann A, Bergmann L, Parra Riaza JC, Sánchez-Soliño O, Sławek J. Gurevich T, et al. Among authors: sanchez solino o. Digit Health. 2024 Aug 30;10:20552076241271847. doi: 10.1177/20552076241271847. eCollection 2024 Jan-Dec. Digit Health. 2024. PMID: 39224799 Free PMC article.

4

Dyskinesia and Pain in Advanced Parkinson's Disease: Post Hoc Analysis from the Phase 3b, Open-Label, Randomized DYSCOVER Study.

Freire-Alvarez E, Vanni P, Kurča E, Lopez-Manzanares L, Kovács N, Spanaki C, Gao T, Bergmann L, Sánchez-Soliño O. Freire-Alvarez E, et al. Among authors: sanchez solino o. Neurol Ther. 2024 Apr;13(2):437-447. doi: 10.1007/s40120-024-00583-z. Epub 2024 Feb 12. Neurol Ther. 2024. PMID: 38345741 Free PMC article.

5

Risk for Mortality in High versus Low Antiparkinsonian Therapy Dose During the First Year of Parkinson's Disease: A Real-World Study.

Barer Y, Sánchez-Soliño O, Chodick G, Grabarnik-John M, Blonder SN, Feurestein-Ganor NL, Bergmann L, Yan CH, Gazit S, Arkadir D. Barer Y, et al. Among authors: sanchez solino o. Adv Ther. 2024 Aug;41(8):3419-3425. doi: 10.1007/s12325-024-02924-8. Epub 2024 Jul 8. Adv Ther. 2024. PMID: 38976124 Free PMC article.

6

Longitudinal Molecular and Serological Evidence of SARS-CoV-2 Infections and Vaccination Status: Community-Based Surveillance Study (CONTACT).

Sánchez-Soliño O, Kilpatrick RD, Johnson C, Fang Y, Ye Y, Alami NN, Zarish K, Krueger WS, Dreyer N, Gray GC. Sánchez-Soliño O, et al. Infect Dis Ther. 2024 Apr;13(4):633-645. doi: 10.1007/s40121-024-00923-4. Epub 2024 Mar 10. Infect Dis Ther. 2024. PMID: 38461480 Free PMC article.

7

Motor and nonmotor symptoms in patients treated with 24-hour daily levodopa-carbidopa intestinal gel infusion: Analysis of the COmedication Study assessing Mono- and cOmbination therapy with levodopa-carbidopa inteStinal gel (COSMOS).

Kovács N, Szász J, Vela-Desojo L, Svenningsson P, Femia S, Parra JC, Sanchez-Soliño O, Bergmann L, Gurevich T, Fasano A. Kovács N, et al. Among authors: sanchez solino o. Parkinsonism Relat Disord. 2022 Dec;105:139-144. doi: 10.1016/j.parkreldis.2022.08.002. Epub 2022 Aug 17. Parkinsonism Relat Disord. 2022. PMID: 36008198 Free article.

8

EpidemiologiCal POpulatioN STudy of SARS-CoV-2 in Lake CounTy, Illinois (CONTACT): Methodology and Baseline Characteristics of a Community-Based Surveillance Study.

Kilpatrick RD, Sánchez-Soliño O, Alami NN, Johnson C, Fang Y, Wegrzyn LR, Krueger WS, Ye Y, Dreyer N, Gray GC. Kilpatrick RD, et al. Among authors: sanchez solino o. Infect Dis Ther. 2022 Apr;11(2):899-911. doi: 10.1007/s40121-022-00593-0. Epub 2022 Feb 2. Infect Dis Ther. 2022. PMID: 35107821 Free PMC article.

9

Levodopa-Carbidopa Intestinal Gel Reduces Dyskinesia in Parkinson's Disease in a Randomized Trial.

Freire-Alvarez E, Kurča E, Lopez Manzanares L, Pekkonen E, Spanaki C, Vanni P, Liu Y, Sánchez-Soliño O, Barbato LM. Freire-Alvarez E, et al. Among authors: sanchez solino o. Mov Disord. 2021 Nov;36(11):2615-2623. doi: 10.1002/mds.28703. Epub 2021 Jul 8. Mov Disord. 2021. PMID: 34236101 Free PMC article. Clinical Trial.

10

Concomitant Medication Usage with Levodopa-Carbidopa Intestinal Gel: Results from the COSMOS Study.

Fasano A, Gurevich T, Jech R, Kovács N, Svenningsson P, Szász J, Parra JC, Bergmann L, Johnson A, Sanchez-Soliño O, Tang Z, Vela-Desojo L. Fasano A, et al. Among authors: sanchez solino o. Mov Disord. 2021 Aug;36(8):1853-1862. doi: 10.1002/mds.28596. Epub 2021 Apr 28. Mov Disord. 2021. PMID: 33908647 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters